Contrast-induced acute kidney injury following coronary angiography: A cohort study of hospitalized patients with or without chronic kidney disease

Nephrology Dialysis Transplantation

Volumn 28, Issue 6, 2013, Pages 1463-1471

  Neyra, Javier A ^a   Shah, Sunay ^b   Mooney, Roberta ^b   Jacobsen, Gordon ^b   Yee, Jerry ^b   Novak, James E ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b HENRY FORD HOSPITAL   (United States)

Author keywords

contrast nephropathy; contrast induced acute kidney injury; coronary angiography; dialysis; mortality; outcomes

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CONTRAST MEDIUM; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE; INOTROPIC AGENT;

ACUTE KIDNEY FAILURE; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; ARTIFICIAL VENTILATION; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; CONTRAST INDUCED ACUTE KIDNEY INJURY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY;

CONTRAST NEPHROPATHY; CONTRAST-INDUCED ACUTE KIDNEY INJURY; CORONARY ANGIOGRAPHY; DIALYSIS; MORTALITY; OUTCOMES;

ACUTE KIDNEY INJURY; AGED; CONTRAST MEDIA; CORONARY ANGIOGRAPHY; FEMALE; GLOMERULAR FILTRATION RATE; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RENAL INSUFFICIENCY, CHRONIC; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 84879872271     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gft082     Document Type: Article

References (61)

1. Nash K, Hafeez A, Hou S. Hospital-acquired renal insufficiency. Am J Kidney Dis 2002; 39: 930-936
2. Bartholomew BA, Harjai KJ, Dukkipati S et al. Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification. Am J Cardiol 2004; 93: 1515-1519
3. Kapoor A, Sinha N, Sharma RK et al. Use of dopamine in prevention of contrast induced acute renal failure-A randomised study. Int J Cardiol 1996; 53: 233-236
4. McCullough PA. Contrast-induced acute kidney injury. J Am Coll Cardiol 2008; 51: 1419-1428
5. Mehran R, Aymong ED, Nikolsky E et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol 2004; 44: 1393-1399
6. Solomon R, Deray G. How to prevent contrast-induced nephropathy and manage risk patients: practical recommendations. Kidney Int Suppl 2006; 100: S51-S53
7. Reddan D, Laville M, Garovic VD. Contrast-induced nephropathy and its prevention: what do we really know from evidencebased findings? J Nephrol 2009; 22: 333-351
8. Weisbord SD, Palevsky PM. Strategies for the prevention of contrast- induced acute kidney injury. Curr Opin Nephrol Hypertens 2010; 19: 539-549
9. Reed M, Meier P, Tamhane UU et al. The relative renal safety of iodixanol compared with low-osmolar contrast media: a metaanalysis of randomized controlled trials. JACC Cardiovasc Interv 2009; 2: 645-654
10. McCullough PA, Brown JR. Effects of intra-arterial and intravenous iso-osmolar contrast medium (iodixanol) on the risk of contrast-induced acute kidney injury: a meta-analysis. Cardiorenal Med 2011; 1: 220-234
11. Stone GW, McCullough PA, Tumlin JA et al. Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial. JAMA 2003; 290: 2284-2291
12. Gupta RK, Kapoor A, Tewari S et al. Captopril for prevention of contrast-induced nephropathy in diabetic patients: a randomised study. Indian Heart J 1999; 51: 521-526
13. Solomon R, Werner C, Mann D et al. Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents. N Engl J Med 1994; 331: 1416-1420
14. Mueller C, Buerkle G, Buettner HJ et al. Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med 2002; 162: 329-336
15. Brar SS, Shen AY, Jorgensen MB et al. Sodium bicarbonate vs sodium chloride for the prevention of contrast medium-induced nephropathy in patients undergoing coronary angiography: a randomized trial. JAMA 2008; 300: 1038-1046
16. Briguori C, Visconti G, Rivera NV et al. Cystatin C and contrastinduced acute kidney injury. Circulation 2010; 121: 2117-2122
17. Briguori C, Visconti G, Focaccio A et al. Renal Insufficiency After Contrast Media Administration Trial II (REMEDIAL II): RenalGuard System in high-risk patients for contrast-induced acute kidney injury. Circulation 2011; 124: 1260-1269
18. Marenzi G, Ferrari C, Marana I et al. Prevention of contrast nephropathy by furosemide with matched hydration: the MYTHOS (Induced Diuresis With Matched Hydration Compared to Standard Hydration for Contrast Induced Nephropathy Prevention) trial. JACC Cardiovasc Interv 2012; 5: 90-97
19. McCullough PA, Wolyn R, Rocher LL et al. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med 1997; 103: 368-375
20. From AM, Bartholmai BJ, Williams AW et al. Mortality associated with nephropathy after radiographic contrast exposure. Mayo Clin Proc 2008; 83: 1095-1100
21. James MT, Ghali WA, Knudtson ML et al. Associations between acute kidney injury and cardiovascular and renal outcomes after coronary angiography. Circulation 2011; 123: 409-416
22. Wi J, Ko YG, Kim JS et al. Impact of contrast-induced acute kidney injury with transient or persistent renal dysfunction on long-term outcomes of patients with acute myocardial infarction undergoing percutaneous coronary intervention. Heart 2011; 97: 1753-1757
23. Solomon RJ, Mehran R, Natarajan MK et al. Contrast-induced nephropathy and long-term adverse events: cause and effect? Clin J Am Soc Nephrol 2009; 4: 1162-1169
24. Weisbord SD, Hartwig KC, Sonel AF et al. The incidence of clinically significant contrast-induced nephropathy following nonemergent coronary angiography. Catheter Cardiovasc Interv 2008; 71: 879-885
25. Inrig JK, Patel UD, Briley LP et al. Mortality, kidney disease and cardiac procedures following acute coronary syndrome. Nephrol Dial Transplant 2008; 23: 934-940
26. Levey AS, Bosch JP, Lewis JB et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-470
27. Jabara R, Gadesam RR, Pendyala LK et al. Impact of the definition utilized on the rate of contrast-induced nephropathy in percutaneous coronary intervention. Am J Cardiol 2009; 103: 1657-1662
28. Harjai KJ, Raizada A, Shenoy C et al. A comparison of contemporary definitions of contrast nephropathy in patients undergoing percutaneous coronary intervention and a proposal for a novel nephropathy grading system. Am J Cardiol 2008; 101: 812-819
29. Thomsen HS, Morcos SK. Contrast media and the kidney: European Society of Urogenital Radiology (ESUR) guidelines. Br J Radiol 2003; 76: 513-518
30. Waikar SS, Wald R, Chertow GM et al. Validity of International Classification of Diseases, Ninth Revision, Clinical Modification Codes for Acute Renal Failure. J Am Soc Nephrol 2006; 17: 1688-1694
31. Conti CR. Contrast nephropathy or contrast creatininopathy. Clin Cardiol 2003; 26: 53-54
32. Mehran R, Brar S, Dangas G. Contrast-induced acute kidney injury. Underappreciated or a new marker of cardiovascular mortality? J Am Coll Cardiol 2010; 55: 2210-2211
33. Sterling KA, Tehrani T, Rudnick MR. Clinical significance and preventive strategies for contrast-induced nephropathy. Curr Opin Nephrol Hypertens 2008; 17: 616-623
34. Weisbord SD, Palevsky PM. Acute kidney injury: kidney injury after contrast media: marker or mediator? Nat Rev Nephrol 2010; 6: 634-636
35. Dangas G, Iakovou I, Nikolsky E et al. Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables. Am J Cardiol 2005; 95: 13-19
36. Parikh CR, Coca SG, Wang Y et al. Long-term prognosis of acute kidney injury after acute myocardial infarction. Arch Intern Med 2008; 168: 987-995
37. Coca SG, Peixoto AJ, Garg AX et al. The prognostic importance of a small acute decrement in kidney function in hospitalized patients: a systematic review and meta-analysis. Am J Kidney Dis 2007; 50: 712-720
38. Coca SG, Yusuf B, Shlipak MG et al. Long-term risk of mortality and other adverse outcomes after acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis 2009; 53: 961-973
39. Rudnick M, Feldman H. Contrast-induced nephropathy: what are the true clinical consequences? Clin J Am Soc Nephrol 2008; 3: 263-272
40. Bagshaw SM, Cruz DN, Aspromonte N et al. Epidemiology of cardio-renal syndromes: workgroup statements from the 7th ADQI Consensus Conference. Nephrol Dial Transplant 2010; 25: 1406-1416
41. Ronco C, Cicoira M, McCullough PA. Cardiorenal syndrome type 1: pathophysiological crosstalk leading to combined heart and kidney dysfunction in the setting of acutely decompensated heart failure. J Am Coll Cardiol 2012; 60: 1031-1042
42. Kingma JG Jr, Vincent C, Rouleau JR et al. Influence of acute renal failure on coronary vasoregulation in dogs. J Am Soc Nephrol 2006; 17: 1316-1324
43. Hassoun HT, Grigoryev DN, Lie ML et al. Ischemic acute kidney injury induces a distant organ functional and genomic response distinguishable from bilateral nephrectomy. Am J Physiol Renal Physiol 2007; 293: F30-F40
44. Go AS, Chertow GM, Fan D et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-1305
45. Marenzi G, Lauri G, Assanelli E et al. Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. J Am Coll Cardiol 2004; 44: 1780-1785
46. Wickenbrock I, Perings C, Maagh P et al. Contrast medium induced nephropathy in patients undergoing percutaneous coronary intervention for acute coronary syndrome: differences in STEMI and NSTEMI. Clin Res Cardiol 2009; 98: 765-772
47. Haase M, Devarajan P, Haase-Fielitz A et al. The outcome of neutrophil gelatinase-associated lipocalin-positive subclinical acute kidney injury: a multicenter pooled analysis of prospective studies. J Am Coll Cardiol 2011; 57: 1752-1761
48. Ronco C, Stacul F, McCullough PA. Subclinical acute kidney injury (AKI) due to iodine-based contrast media. Eur Radiol 2013; 23: 319-323
49. Cirit M, Toprak O, Yesil M et al. Angiotensin-converting enzyme inhibitors as a risk factor for contrast-induced nephropathy. Nephron Clin Pract 2006; 104: c20-c27
50. Kiski D, Stepper W, Brand E et al. Impact of renin-angiotensinaldosterone blockade by angiotensin-converting enzyme inhibitors or AT-1 blockers on frequency of contrast medium-induced nephropathy: a post-hoc analysis from the Dialysis-versus-Diuresis (DVD) trial. Nephrol Dial Transplant 2010; 25: 759-764
51. Rim MY, Ro H, Kang WC et al. The effect of renin-angiotensinaldosterone system blockade on contrast-induced acute kidney injury: a propensity-matched study. Am J Kidney Dis 2012; 60: 576-582
52. Schoolwerth AC, Sica DA, Ballermann BJ et al. Renal considerations in angiotensin converting enzyme inhibitor therapy: a statement for healthcare professionals from the Council on the Kidney in Cardiovascular Disease and the Council for High Blood Pressure Research of the American Heart Association. Circulation 2001; 104: 1985-1991
53. Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Int 2012; 2: 1-138
54. Roger VL, Jacobsen SJ, Pellikka PA et al. Gender differences in use of stress testing and coronary heart disease mortality: a population- based study in Olmsted County, Minnesota. J Am Coll Cardiol 1998; 32: 345-352
55. Iakovou I, Dangas G, Mehran R et al. Impact of gender on the incidence and outcome of contrast-induced nephropathy after percutaneous coronary intervention. J Invasive Cardiol 2003; 15: 18-22
56. Ma G, Yu D, Cai Z et al. Contrast-induced nephropathy in postmenopausal women undergoing percutaneous coronary intervention for acute myocardial infarction. Tohoku J Exp Med 2010; 221: 211-219
57. Kiski D, Stepper W, Breithardt G et al. Impact of female gender on frequency of contrast medium-induced nephropathy: post hoc analysis of dialysis versus diuresis trial. J Womens Health (Larchmt) 2010; 19: 1363-1368
58. Mueller C, Buerkle G, Perruchoud AP et al. Female sex and risk of contrast nephropathy after percutaneous coronary intervention. Can J Cardiol 2004; 20: 505-509
59. Prasad P, Epstein F. Changes in medullary pO2 during water diuresis as evaluated by blood oxygenation level dependent magnetic resonance imaging. Kidney Int 1999; 55: 294-298
60. Kuhlik A, Elahi D, Epstein F. Decline in urinary excretion of dopamine and PGE2 with age. Ger Nephrol Urol 1995; 5: 79-83
61. Mathieu D, Neviere R, Billard V et al. Effects of bicarbonate therapy on hemodynamics and tissue oxygenation in patients with lactic acidosis: a prospective, controlled clinical study. Crit Care Med 1991; 19: 1352-1356